Data / Drug companies / Low Molecular Weight Heparin
Low Molecular Weight Heparin drugs: 3 drugs from 19 companies in the FDA NDC directory
Low Molecular Weight Heparin is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 174 products in this class from 19 companies, covering 3 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on May 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 19Companies
- 174Products
- 3Drugs by generic name
Drugs in the Low Molecular Weight Heparin class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Enoxaparin sodium | 158 | 18 |
| Dalteparin sodium | 9 | 1 |
| Enoxaparin sodium injection,usp | 7 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Fresenius Kabi USA, LLC | 28 | injection | Authorized generics (NDA) | June 18, 2019 |
| Meitheal Pharmaceuticals Inc. | 16 | injection | Generic drugs (ANDA) | June 14, 2022 |
| Sanofi-Aventis U.S. LLC | 16 | injection | New drug applications (NDA) | March 29, 1993 |
| Sandoz Inc | 14 | injection; injection, solution | Generic drugs (ANDA) | March 15, 2023 |
| BluePoint Laboratories | 9 | injection | Generic drugs (ANDA) | May 1, 2025 |
| Pfizer Laboratories Div Pfizer Inc | 9 | injection | New drug applications (NDA) | October 17, 2022 |
| Amphastar Pharmaceuticals, Inc. | 8 | injection | Generic drugs (ANDA) | November 11, 2019 |
| Sanofi-Aventis U.S. LLC | 8 | injection | Authorized generics (NDA) | October 3, 2011 |
| Be Pharmaceuticals Inc. | 7 | injection | Generic drugs (ANDA) | June 16, 2023 |
| Cardinal Health 107, LLC | 7 | injection | Generic drugs (ANDA) | July 16, 2024 |
| Gland Pharma Limited | 7 | injection | Generic drugs (ANDA) | July 11, 2023 |
| Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 7 | injection | Generic drugs (ANDA) | May 1, 2026 |
| Hepalink USA Inc. | 7 | injection, solution | Generic drugs (ANDA) | March 15, 2023 |
| Italfarmaco SpA | 7 | injection, solution | Generic drugs (ANDA) | April 1, 2021 |
| NorthStar Rx LLC | 7 | injection | Generic drugs (ANDA) | December 1, 2019 |
| NorthStar RxLLC | 7 | injection, solution | Generic drugs (ANDA) | March 15, 2023 |
| Zydus Pharmaceuticals USA Inc. | 7 | injection, solution | Generic drugs (ANDA) | April 1, 2021 |
| Sagent Pharmaceuticals | 2 | injection | Generic drugs (ANDA) | October 1, 2023 |
| Civica, Inc. | 1 | injection | Generic drugs (ANDA) | November 1, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection | 139 | 79.9% |
| Injection, solution | 35 | 20.1% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.